TherapeuticsMD Inc - TXMD - Financial Statement Analysis
All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.
In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.
Financial statement analysis updated: December 1, 2013
TherapeuticsMD Inc - SIC # 2834
|Ticker||Exchange||SIC #||Website||Latest Ticker|
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for TherapeuticsMD Inc
TherapeuticsMD appoints Joel S. Krasnow as Chief Scientific Officer - Dec 4th, 2013 5:06 am
TherapeuticsMD Appoints Joel S. Krasnow, M.D. as Chief Scientific Officer - Dec 4th, 2013 5:00 am
TherapeuticsMD To Present At 25th Annual Piper Jaffray Healthcare Conference - Nov 22nd, 2013 6:00 am
TherapeuticsMD Applauds Congressional Leadership on Passage of Drug Quality and Security Act - Nov 19th, 2013 5:00 am
TherapeuticsMD: Legislation To Provide Near-Term Catalyst For Investors; Maintaining Positive Outlook - Nov 18th, 2013 12:13 pm
View All Current Headlines >>